Exhibit 99.1
Pursuant to General Instruction number 4(b)(v) to Form 4, the following
additional reporting persons are covered by this joint filing:
Name: Foresite Capital Fund II, L.P.
Foresite Capital Management III, LLC
Foresite Capital Fund III, L.P.
James B. Tananbaum
Address: Foresite Capital
101 California Street
Suite 4100
San Francisco, CA 94111
Designated Filer: Foresite Capital Management II, LLC
Issuer and Ticker Symbol: Aimmune Therapeutics, Inc. (AIMT)
Date of Event Requiring Statement: August 24, 2015
Signature: FORESITE CAPITAL MANAGEMENT II, LLC
By: /s/ Dennis D. Ryan
---------------------------------------
Dennis D. Ryan
Chief Financial Officer
FORESITE CAPITAL FUND II, L.P.
By: Foresite Capital Management II, LLC
Its General Partner
By: /s/ Dennis D. Ryan
---------------------------------------
Dennis D. Ryan
Chief Financial Officer
FORESITE CAPITAL MANAGEMENT III, LLC
By: /s/ Dennis D. Ryan
---------------------------------------
Dennis D. Ryan
Chief Financial Officer
FORESITE CAPITAL FUND III, L.P.
By: Foresite Capital Management III, LLC
Its General Partner
By: /s/ Dennis D. Ryan
---------------------------------------
Dennis D. Ryan
Chief Financial Officer
/s/ James B. Tananbaum
-------------------------------------------
James B. Tananbaum
Foresite Capital Fund II
Filed: 26 Aug 15, 12:00am